Down-regulation of ERAP1 mRNA expression in non-small cell lung cancer

BMC Cancer

Table 1 Characteristics of NSCLC patients

Age	n	Min	Q1^a	Median	Q3^a	Max	Variability¹
Men	36	52	61	66.5	71	81	7
Women	36	49	60	64	68	81	5
All	72	49	60	65	70	81	6
Histological type	LUSC	LUAD	Other	% LUSC	% LUAD	% Other	Variability²
Men	16	13	7	44	36	19	0.95
Women	6	26	4	17	72	11	0.71
All	22	39	11	31	54	15	0.89
TNM^c	T1	T2	T3	T4	N0	N1	N2
Men	9	13	11	3	24	12	0
Women	15	15	6	0	27	4	5
All	24	28	17	3	51	16	5
% All	33	39	24	4	71	22	7
Tumor stage	I	II	III	% I	% II	% III	Variability²
Men	16	13	7	44	36	19	0.95
Women	24	6	6	67	17	17	0.79
All	40	19	13	56	26	18	0.9
Smoking	0 p-y	5.5	15.5	25.5	35.5	45.5	Variability²
Men	0	1	4	6	17	8	0.74
Women	4	1	5	11	13	2	0.84
All	4	2	9	17	30	10	0.84
% All	5	3	12	24	42	14	-
OS	All patients			Death patients			Variability^1b
OS	Min	Median	Max	Min	Median	Max
Men	0.7	23.0	35.0	0.7	10.9	21.3	10.7
Women	5.2	25.8	35.4	5.2	9.2	22.2	7.5
All	0.7	24.8	35.4	0.7	9.2	22.2	9.1

^a1st and 3rd quartile
^ball patients
^call patients M0
¹\({S}_{n}\)-typical difference between two randomly chosen patients
²Normalized Shannon’s entropy – measure between [0,1], where entropy = 1 is maximal variability; For more information see Statistical methods
LUSC Lung squamous cell carcinoma, LUAD Lung adenocarcinoma, p-y Pack-years, OS Overall survival

ISSN: 1471-2407